ACS Global, Inc. (AMCY)
ACS Global, Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Red Bank, NJ, US. The stock last traded at $3.00, down 40.00% on the session, giving a market capitalisation of $171.3M. Its beta of 0.00 implies it has historically moved less than the broad market.
ACS Global, Inc. specializes in the acquisition, meticulous processing, and secure, long-term cryogenic storage of stem cells. The company enables individuals to privately bank their own stem cells for potential future applications in cellular therapy. Headquartered in Red Bank, New Jersey, the firm adopted its current name, ACS Global, Inc., in June 2011, having previously operated as American CryoStem Corp.
ACS Global, Inc. is most often compared with the following Healthcare names: